ALCAM and breast carcinoma: Low and colleagues, in their genome-wide association studies (GWAS) [56], discovered that 3q13.11 (ALCAM), together 21q22.12 (CLIC6-RUNX1), two novel loci, are potential susceptibility indicators in Japanese breast cancer patients.